Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Plasma Ceramides and Other Sphingolipids in Relation to Incident Prediabetes in a Longitudinal Biracial Cohort

The Journal of Clinical Endocrinology & Metabolism(2024)10.1210/clinem/dgae179Source: DataRank Database

Plasma Ceramides and Other Sphingolipids in Relation to Incident Prediabetes in a Longitudinal Biracial Cohort is a research paper published in The Journal of Clinical Endocrinology & Metabolism (2024). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 1.93)OA: bronzeTopics (45)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Peace Asuzu,Jim Y. Wan ORCID,Richard C. Grambergs,Frankie B. Stentz ORCID,Nawajes Mandal ORCID

Live enrichment

PubMed:38501230 PMC:PMC11403313 OpenAlex:https://openalex.org/W4392954081

NIDDK NIH HHS

Grant: R01 DK128129

National Institute of Diabetes Digestive and Kidney Diseases

Grant: R01 R01DK067269

NIDDK NIH HHS

Grant: R01 DK067269

FWCI

1.93

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

bronzeLicense: https://academic.oup.com/pages/standard-publication-reuse-rights

journalhttps://academic.oup.com/jcem/article-pdf/109/10/2530/59135662/dgae179.pdf

publisherhttps://academic.oup.com/jcem/article-pdf/109/10/2530/59135662/dgae179.pdf

publisherhttps://academic.oup.com/jcem/advance-article-pdf/doi/10.1210/clinem/dgae179/57331684/dgae179.pdf

journalhttps://doi.org/10.1210/clinem/dgae179

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38501230

Fields of Study

Sphingolipid Metabolism and SignalingMetabolomics and Mass Spectrometry StudiesDiabetes, Cardiovascular Risks, and Lipoproteins

MeSH Terms

WhiteAdultBlack or African AmericanBlood GlucoseCeramidesDiabetes Mellitus, Type 2FemaleFollow-Up StudiesGlucose Tolerance TestHumansInsulin ResistanceLongitudinal StudiesMaleMiddle AgedPrediabetic StateSphingolipidsCohort StudiesBiomarkersIncidenceCase-Control StudiesGlucose IntoleranceDisease ProgressionWhite People

Keywords

PrediabetesSphingolipidCohortDemographyMedicineInternal medicineCohort studyPsychologyEndocrinologyBiologyDiabetes mellitusType 2 diabetesSociologyGeneticsBiomarkersImpaired glucose toleranceImpaired fasting glucoseSphingomyelinsRace/ethnicity

Sustainable Development Goals

SDG 0: Good health and well-being